
Arcadia Biosciences
(NASDAQ) RKDA
Arcadia Biosciences Financials at a Glance
Market Cap
$2.85M
Revenue (TTM)
$5.17M
Net Income (TTM)
$5.07M
EPS (TTM)
$-3.71
P/E Ratio
-0.44
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$1.67
Volume
0
Open
$1.63
Price
$1.67
Volume
0
Open
$1.63
Previous Close
$1.67
Daily Range
$1.60 - $1.70
52-Week Range
$1.53 - $6.71
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$1.67
Volume
0
Open
$1.63
Previous Close
$1.67
Daily Range
$1.60 - $1.70
52-Week Range
$1.53 - $6.71
RKDA News
RKDA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Arcadia Biosciences
Industry
Food Products
Sector
Consumer StaplesEmployees
9
CEO
Thomas J. Schaefer, CFA, MBA
Website
www.arcadiabio.comHeadquarters
Davis, CA 95618, US
RKDA Financials
Key Financial Metrics (TTM)
Gross Margin
38%
Operating Margin
-66%
Net Income Margin
-98%
Return on Equity
-64%
Return on Capital
-54%
Return on Assets
-59%
Earnings Yield
-2.27%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.85M
Shares Outstanding
1.73M
Volume
0
Short Interest
0.00%
Avg. Volume
36.53K
Financials (TTM)
Gross Profit
$2.08M
Operating Income
$3.65M
EBITDA
$7.50M
Operating Cash Flow
$9.63M
Capital Expenditure
$16.00K
Free Cash Flow
$9.64M
Cash & ST Invst.
$4.24M
Total Debt
$155.00K
Arcadia Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.30M
-15.3%
Gross Profit
$418.00K
-17.2%
Gross Margin
32.10%
N/A
Market Cap
$2.85M
N/A
Market Cap/Employee
$317.14K
N/A
Employees
9
N/A
Net Income
$856.00K
+153.1%
EBITDA
$858.00K
+148.9%
Quarterly Fundamentals
Net Cash
$5.88M
-5.5%
Accounts Receivable
$831.00K
-69.3%
Inventory
$1.46M
+74.5%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-59.03%
N/A
Return on Invested Capital
-54.01%
N/A
Free Cash Flow
$257.00K
+85.3%
Operating Cash Flow
$257.00K
+85.3%
